公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
公司地址 2000 Sierra Point Parkway, Suite 900, Brisbane, CA, USA, 94005
電話號碼 +1 650 242-8052
傳真號碼 --
公司網頁 https://www.pacira.com
員工數量 829
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Brendan P. Teehan Chief Commercial Officer -- 21/01/2025
Mr. Frank D. Lee Director and Chief Executive Officer 美元 896.54K 26/02/2026
Mr. Jonathan Slonin Chief Medical Officer 美元 535.00K 29/04/2025
Mr. Shawn M. Cross Chief Financial Officer 美元 100.96K 26/02/2026
Mr. Daryl Gaugler Executive Vice President, Commercial Operations 美元 511.81K 21/01/2025
Ms. Lauren Riker Principal Accounting Officer and Senior Vice President, Finance 美元 374.56K 26/02/2026
Ms. Kristen Marie Williams Chief Administrative Officer and Secretary 美元 519.26K 29/04/2025
Ms. Krys Corbett Chief Business Officer -- 21/01/2025
 
董事會成員
董事會 職務 更新日期
Ms. Laura A. Brege Chairman of the Board 26/02/2026
Mr. Frank D. Lee Director and Chief Executive Officer 26/02/2026
Mr. Michael J. Yang Independent Director 26/02/2026
Dr. Marcelo Bigal, M.D.,PhD Independent Director 26/02/2026
Dr. Mark I. Froimson, M.D. Independent Director 26/02/2026
Ms. Alethia Young Independent Director 26/02/2026
Dr. Samit Hirawat, M.D. Independent Director 28/01/2026
Governor Christopher J. Christie Independent Director 26/02/2026
Mr. Abraham N. Ceesay, M.B.A. Independent Director 26/02/2026
Dr. Mark A. Kronenfeld, M.D. Independent Director 26/02/2026
 
所屬ETF (更新日期: 02/05/2026 05:11)
代號 名稱 佔比% 持有日期
IHEiShares US Pharmaceuticals ETF0.27%29/04/2026
FSMDFidelity Small-Mid Multifactor ETF0.26%29/04/2026
BRNYBurney U.S. Factor Rotation ETF0.26%29/04/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.25%29/04/2026
PSCPrincipal US Small Cap ETF0.22%29/04/2026
FESMFidelity Enhanced Small Cap ETF0.20%29/04/2026
AVSCAvantis US Small Cap Equity ETF0.20%29/04/2026
RNINBushido Capital US SMID Cap Equity ETF0.20%29/04/2026
SLYSPDR® S&P 600 Small Cap ETF0.18%31/05/2023
ITOTiShares Core S&P Total US Stock Mkt ETF0.17%29/04/2026
SIXSETC 6 Meridian Small Cap Equity ETF0.16%29/04/2026
PINKSimplify Health Care ETF0.16%29/04/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.12%29/04/2026
VIOGVanguard S&P Small-Cap 600 Growth ETF0.12%31/03/2026
EESWisdomTree US SmallCap Earnings ETF0.12%28/04/2026
VFVAVanguard US Value Factor ETF0.11%31/03/2026
JPSEJPMorgan Divers Ret US Small Cap Eq ETF0.09%29/04/2026
SIXLETC 6 Meridian Low Beta Eq Strat ETF0.09%29/04/2026
RWJInvesco S&P SmallCap 600 Revenue ETF0.09%29/04/2026
VFMFVanguard US Multifactor ETF0.08%31/03/2026
  1   2    3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.